Sujal M. Patel, CEO, President, and Secretary at Nautilus Biotechnology, Inc. (NAUT), bought 283,500 shares at $0.67 ($192K) on 2025-09-05, disclosed to the SEC on 2025-09-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.67 | 116,500 | $78K | 40.7% |
| 2 | $0.68 | 83,500 | $57K | 29.6% |
| 3 | $0.68 | 83,500 | $57K | 29.6% |
| Total | $0.68 avg | 283,500 | $192K | 100% |
| Filing → |
| NAUT | BUY | 2024-03-11 | $41K | — | Filing → |
| NAUT | BUY | 2024-03-07 | $154K | — | Filing → |
| NAUT | BUY | 2022-08-08 | $268K | — | Filing → |